EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios

Ejemplares similares

• EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
  por: Vasconcelos, Pedro E.N.S., et al.
  Publicado: (2020)
• EGFR exon 20 insertion variants A763_Y764insFQEA and D770delinsGY confer favorable sensitivity to currently approved EGFR-specific tyrosine kinase inhibitors
  por: Yang, Guangjian, et al.
  Publicado: (2022)
• Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations
  por: Vasconcelos, Pedro E.N.S., et al.
  Publicado: (2020)
• Not All EGFR Exon 20 Insertions Are Created Equal
  por: Lin, Yen-Ting, et al.
  Publicado: (2020)
• Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations
  por: Lin, Ling, et al.
  Publicado: (2020)